krishna institute of medical sciences: Despite weak Q1 show, this stock has a 45% upside
Brokerage firms remain positive on (KIMS) despite a weaker-than-expected performance in the June 2022 quarter.
Despite a muted Q1 performance from the hospital chain, analysts see an up to 45 per cent upside potential in the counter as…